Australia’s Leading Clinic Network
Support For Healthcare Providers
Did You Know?
In 2016, the Australian federal government passed legislation authorising a range of cannabinoid medicines to be prescribed to patients by registered healthcare professionals.
Therapeutic Goods Administration (TGA) enables doctors to access cannabis medicines for their patients where clinically appropriate. The current system allows any registered health professional to prescribe cannabinoid medicines either through the Special Access Scheme (SAS) or the Authorised Prescriber Scheme (APS). Up until February 2021, 99,000 Special Access Scheme Category B (SAS-B) applications had been approved.
Read below for more information on Tetra Health’s Services.
Tetra Health Services
Tetra Health is a trusted Australian based clinic network led by a collaborative team of medical professionals. Tetra has a team of specialist Authorised Prescribers that will assess a patient’s medical condition to determine if cannabinoids might be an appropriate treatment, and support that patient’s treatment via Tetra’s team of specialist nurses.
Medical practitioners who may not wish to prescribe medicinal cannabinoids can easily refer their patients to Tetra Health for assessment.
Tetra Health’s medical team are experts in prescribing and follow all TGA and State guidelines when considering medical cannabinoids as a potential treatment option for patients.
Patient safety is our priority. All patients are screened for contraindications and potential drug interactions, and titration is based around safe and controlled administration. Our medical team closely monitors patients for adverse events while working towards positive treatment outcomes.
Refer your patient below and a Tetra nurse will contact your patient within 24 hours. Our medical team will provide you with ongoing progress reports to ensure both you and your patients are supported throughout this process.
Questions? Contact our medical team on 1800-861-099 or [email protected] to learn more.